Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

Rizzo WB.

Biochim Biophys Acta. 2014 Mar;1841(3):377-89. doi: 10.1016/j.bbalip.2013.09.001. Review.

2.

The role of fatty aldehyde dehydrogenase in epidermal structure and function.

Rizzo WB.

Dermatoendocrinol. 2011 Apr;3(2):91-9. doi: 10.4161/derm.3.2.14619.

3.

Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.

Rizzo WB, Craft DA, Somer T, Carney G, Trafrova J, Simon M.

J Lipid Res. 2008 Feb;49(2):410-9.

4.

Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Rizzo WB, S'Aulis D, Jennings MA, Crumrine DA, Williams ML, Elias PM.

Arch Dermatol Res. 2010 Aug;302(6):443-51. doi: 10.1007/s00403-009-1022-y.

8.

Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Naganuma T, Takagi S, Kanetake T, Kitamura T, Hattori S, Miyakawa T, Sassa T, Kihara A.

J Biol Chem. 2016 May 27;291(22):11676-88. doi: 10.1074/jbc.M116.714030.

PMID:
27053112
9.

Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Malheiro AR, da Silva TF, Brites P.

J Inherit Metab Dis. 2015 Jan;38(1):111-21. doi: 10.1007/s10545-014-9795-3. Review.

PMID:
25432520
10.

Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.

Rizzo WB, Lin Z, Carney G.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):297-307.

PMID:
11306053
11.

Sjögren-Larsson syndrome.

Rizzo WB.

Semin Dermatol. 1993 Sep;12(3):210-8. Review.

PMID:
8217559
12.

Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.

Haug S, Braun-Falco M.

Gene Ther. 2006 Jul;13(13):1021-6.

PMID:
16525484
14.

Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.

Verhoeven NM, Jakobs C, Carney G, Somers MP, Wanders RJ, Rizzo WB.

FEBS Lett. 1998 Jun 16;429(3):225-8.

15.

Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Davis K, Holden KR, S'Aulis D, Amador C, Matheus MG, Rizzo WB.

J Child Neurol. 2013 Oct;28(10):1259-65. doi: 10.1177/0883073812460581.

PMID:
23034980
17.

Role of lipids in the formation and maintenance of the cutaneous permeability barrier.

Feingold KR, Elias PM.

Biochim Biophys Acta. 2014 Mar;1841(3):280-94. doi: 10.1016/j.bbalip.2013.11.007. Review.

PMID:
24262790
18.

Incomplete Sjögren-Larsson syndrome in two Japanese siblings.

Kawakami T, Saito R, Fujikawa Y, Kazama H, Shinomiya N, Yamaguchi K, Yamaguchi Y, Aoki T, Kobayashi T.

Dermatology. 1999;198(1):93-6.

PMID:
10026413
19.

Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds.

Keller MA, Watschinger K, Lange K, Golderer G, Werner-Felmayer G, Hermetter A, Wanders RJ, Werner ER.

J Lipid Res. 2012 Jul;53(7):1410-6. doi: 10.1194/jlr.D025650.

20.

Sjogren-Larsson syndrome.

Dutra LA, Braga-Neto P, Pedroso JL, Povoas Barsottini OG.

Adv Exp Med Biol. 2012;724:344-50. doi: 10.1007/978-1-4614-0653-2_26. Review.

PMID:
22411255
Items per page

Supplemental Content

Support Center